View older revisions Content changed at 2021-06-03, 1400/03/13

Protocol summary

Study aim
Comparison of the effect of hyoscine and EMLA cream on Catheter related bladder discomfort in non-urological surgery
Design
Two arm parallel group randomized trial with blinded participants, outcome assessment and statistical analyst.
Settings and conduct
The study will assess the effectiveness of Hyoscine on CRBD compared to the EMLA group. The participants will assign equally to the groups. This study will carry out at Bohlool Hospital affiliated to Gonabad University of Medical Sciences. The participants, outcome assessment and statistical analyst will blind to the groups.
Participants/Inclusion and exclusion criteria
Having ASA class 1 or 2 , 18 to 60 years old, Elective surgery, general anesthesia and requires urinary catheterization, No history of bladder obstruction, overactive bladder, kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder. Non-urological surgeries. No history of allergy to lidocaine or prilocaine and hyoscine, No cardiac dysrhythmia. No obvious cognitive impairment Do not take sedatives for a long time. No kidney or liver failure. No history of drug use. No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure. Medications used before and during anesthesia should be the same. Unwillingness to cooperate. Patients should also undergo urological surgery during the operation. Any effective intervention or medication in addition to medications used in the routine anesthesia process
Intervention groups
group 1: Hyoscine N-butyl bromide, at a dose of 20 mg intravenously within one minute before extubating. group 2, 5 g of EMLA cream and group 3 (control): 5 g of Lidocaine jell, both of these is made in Iran, applicating before placing a urinary catheter for a patient
Main outcome variables
Incidence of CRBD

General information

Reason for update
Adding control group to study, changing the measurement time and modifying randomization mode and sample size
Acronym
CRBD
IRCT registration information
IRCT registration number: IRCT20210228050530N1
Registration date: 2021-04-07, 1400/01/18
Registration timing: prospective

Last update: 2021-06-03, 1400/03/13
Update count: 1
Registration date
2021-04-07, 1400/01/18
Registrant information
Name
Faezeh Khajeh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 5725 3729
Email address
fa.freedman1992@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-04-21, 1400/02/01
Expected recruitment end date
2021-08-22, 1400/05/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD) in patients undergoing non-urologic surgery
Public title
The effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD)
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Having ASA class 1 or 2 according to the anesthesiologist record Age between 18 and 60 years Elective surgery with general anesthesia and requires urinary catheterization No history of bladder obstruction, overactive bladder, severe kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder Non-urological surgeries. No history of allergy to lidocaine or prilocaine and hyoscine No cardiac dysrhythmia No obvious cognitive impairment Do not take sedatives for a long time No kidney or liver failure No history of drug use No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure Medications used before and during anesthesia should be the same
Exclusion criteria:
Unwillingness to cooperate Patients should also undergo urological surgery during the operation. Any effective intervention or medication in addition to medications used in the routine anesthesia process
Age
From 18 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 105
Randomization (investigator's opinion)
Randomized
Randomization description
After obtaining written consent from the participants, the patients were selected through purposive sampling method and were randomly assigned to control and intervention groups based on the permutation blocks method. To do this, the letter C, B and A will be considered for the 2% lidocaine gel (control group), EMLA and Hyoscine + lidocaine groups, respectively. Possible modes in permutation blocks method are six modes include (BCA, ACB, ABC, BAC, CBA, and CAB). Each mode will be written on a card and the cards will be assigned the number one to six. Then 35 mode is selected by using a table of random numbers, 35 numbers between 1 and 6 will be selected. The resulting blocks will be listed in order. Then, based on the list, the selected patients are divided into three groups. In order to homogenize the gender, a separate list is prepared for each of those.
Blinding (investigator's opinion)
Triple blinded
Blinding description
Prior to anesthesia and allocation to groups, for participants who meet the inclusion criteria will be described control and two intervention groups. The participants will be explained that they will allocate into two interventions or control groups. At the end of the study, they are informed about their group. The evaluator of primary (CRBD) and secondary outcomes (severity of CRBD) will be a person (Apart from the main researchers) who does not know the patient is in the intervention or control groups. One, two and three will assign to two interventions and control groups, respectively. Therefore, the statistical analyst will not aware of the study groups and only will know the groups as a code.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Gonabad University of Medical Sciences
Street address
No. 36, Alley 5, Resalat St
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Approval date
2021-02-27, 1399/12/09
Ethics committee reference number
IR.GMU.REC.1399.125

Health conditions studied

1

Description of health condition studied
Catheter related bladder discomfort
ICD-10 code
N32.8
ICD-10 code description
Other specified disorders of bladder

Primary outcomes

1

Description
Incidence of Catheter related bladder discomfort
Timepoint
In one, two, three and four hours after the end of anesthesia
Method of measurement
Checklist for the incidence of Catheter related bladder discomfort

Secondary outcomes

1

Description
Severity of CRBD
Timepoint
In one, two, three and four hours after the end of anesthesia.
Method of measurement
Checklist of severity of CRBD of Catheter related bladder discomfort

Intervention groups

1

Description
Intervention group 1: Hyoscine N-butyl bromide made in Iran, Elixir Company, at a dose of 20 mg intravenously within one minute before extubating of a patient under non-urological surgery.
Category
Prevention

2

Description
Intervention group 2: 5 g of EMLA cream made in Iran, Iran Daroo Company before placing a urinary catheter for a patient undergoing non-urological surgery
Category
Prevention

3

Description
Control group: 5 g lidocaine jell made in Iran, Iran Daroo Company before placing a urinary catheter for a patient undergoing non-urological surgery
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Bohlool Hospital
Full name of responsible person
Saeed Mehrabi
Street address
No. 36, Alley 5, Resalat St
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Phone
+98 51 5725 3729
Email
fa.freedman1992@gmail.com
Web page address
http://bohlool.gmu.ac.ir/

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Gonabad University of Medical Sciences
Full name of responsible person
Dr. Shahla Khosravan
Street address
No. 36, Alley 5, Resalat St.
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Phone
+98 51 5725 3729
Email
fa.freedman1992@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Gonabad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Gonabad University of Medical Sciences
Full name of responsible person
Faezeh Khajeh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
No. 36, Alley 5, Resalat St.
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Phone
+98 51 5725 3729
Email
fa.freedman1992@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Gonabad University of Medical Sciences
Full name of responsible person
Faezeh Khajeh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
No. 36, Alley 5, Resalat St.
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Phone
+98 51 5725 3729
Email
fa.freedman1992@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Gonabad University of Medical Sciences
Full name of responsible person
Faezeh Khajeh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
No. 36, Alley 5, Resalat St.
City
Gonabad
Province
Razavi Khorasan
Postal code
9691637744
Phone
+98 51 5725 3729
Email
fa.freedman1992@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
Thesis report All research information will be published after being unidentified.
When the data will become available and for how long
Since 1401
To whom data/document is available
Everyone can request research results.
Under which criteria data/document could be used
Upon formal request through other members of the research team
From where data/document is obtainable
Library of Gonabad University of Medical Sciences
What processes are involved for a request to access data/document
An official request to Gonabad University of Medical Sciences
Comments
Loading...